Optimizing prevention of HIV mother to child transmission: Duration of antiretroviral therapy and viral suppression at delivery among pregnant Malawian women-Reference-Cited by-同舟云学术

Optimizing prevention of HIV mother to child transmission: Duration of antiretroviral therapy and viral suppression at delivery among pregnant Malawian women

Published:2018-04-03 Issue:4 Volume:13 Page:e0195033
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Chagomerana Maganizo B.^ORCID,Miller William C.,Tang Jennifer H.,Hoffman Irving F.,Mthiko Bryan C.,Phulusa Jacob,John Mathias,Jumbe Allan,Hosseinipour Mina C.

Funder

National Institutes of Health

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference36 articles.

1. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team;LM Mofenson;The New England journal of medicine,1999

2. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group;PM Garcia;The New England journal of medicine,1999

3. Predictors of intrauterine and intrapartum transmission of HIV-1 among Tanzanian women;W Fawzi;AIDS (London, England),2001

4. HIV-1/AIDS and maternal and child health in Africa;F Dabis;Lancet,2002

5. HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load;AN Phillips;JAMA: the journal of the American Medical Association,2001

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Viral load non-suppression status among women exposed to Dolutegravir-based versus Efavirenz-based regimens in Ethiopia: A before-and-after study;PLOS ONE;2024-06-10

2. Association of comprehensiveness of antiretroviral care and detectable HIV viral load suppression among pregnant and postpartum women in the Democratic Republic of the Congo: a cross-sectional study;Frontiers in Global Women's Health;2024-06-05

3. Three-year outcomes for women newly initiated on lifelong antiretroviral therapy during pregnancy – Malawi option B+;AIDS Research and Therapy;2023-06-12

4. Intervention Fidelity to VITAL Start (Video Intervention to Inspire Treatment Adherence for Life) in a Randomized Controlled Trial Among Women Living With HIV in Malawi;Health Promotion Practice;2023-06-06

5. The mother-to-child transmission of HIV-1 and profile of viral reservoirs in pediatric population: A systematic review with meta-analysis of the Cameroonian studies;PLOS ONE;2023-01-17